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Abstract
Background: Human immunodeficiency virus (HIV) infection is associated with an increased risk for human herpes 
viruses (HHVs) and their related diseases and they frequently cause disease deterioration and therapeutic failures. 
Methods for limiting the transmission of HHVs require a better understanding of the incidence and infectivity of oral 
HHVs in HIV-infected patients. This study was designed to determine the seroprevalence of human herpes viruses 
(CMV, HSV 2, EBV-1, VZV) antibodies and to evaluate their association with age, sex as well as other demographic and 
behavioral factors.
Results: A study of 200 HIV positive patients from Eastern India attending the Calcutta Medical College Hospital, 
Kolkata, West Bengal, Apex Clinic, Calcutta Medical College Hospital and ART Center, School of Tropical Medicine, 
Kolkata, West Bengal was done. Serum samples were screened for antibodies to the respective viruses using the 
indirect ELISA in triplicates.
CytoMegalo virus (CMV), Herpes Simplex virus type 2 (HSV-2), Varicella Zoster virus (VZV), and Epstein Barr virus (EBV-1) were
detected in 49%, 47%, 32.5%, and 26% respectively.
Conclusion: This study has contributed baseline data and provided insights in viral OI and HIV co-infection in Eastern 
India. This would undoubtedly serve as a basis for further studies on this topic.
Background
The HIV/AIDS is a global epidemic and approximately 40
million people are living with HIV/AIDS worldwide [1].
About 95% of all HIV/AIDS infected people are living in
developing countries. It is estimated that India is cur-
rently harboring about 5.134 million HIV infected cases
and comprises of 65% cases of Southeast Asia. The HIV/
AIDS pandemic in India has extended beyond the com-
mon classification of high-risk groups and now is com-
mon among the general population [2,3]. The nation is
indeed at the threshold of an exponential growth of this
epidemic. Opportunistic Infections (OIs) have been rec-
ognized as common complications of HIV infection due
to immune deficiency. OI is the main reason behind hos-
pitalization and substantial morbidity in HIV infected
patients [4]. It necessitates toxic and expensive therapies
and reduces the expected life span of such patients. Virtu-
ally all HIV-related mortality is preceded by opportunis-
tic infection [5]. OIs encompass a wide variety of
microorganisms that produce fulminant infections in
immunocompromised HIV seropositive patients. Viral
pathogens causing OI evoke a spectrum of illness ranging
from asymptomatic to fulminant diseases in HIV-
infected individuals. Since the onset of the acquired
immunodeficiency syndrome (AIDS) epidemic in 1980;
human herpes viruses have resulted in many of the sec-
ondary manifestations of human immunodeficiency virus
(HIV) infection such as Painful rash due to Painful rash
caused by herpes zoster [6,7]. Almost 45 million people
worldwide have been infected with HIV, and prior to
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highly active antiretroviral therapy (HAART), more than
75% of all HIV-infected individuals developed HHV-
related symptoms. The advent of HAART has decreased
the incidence of opportunistic HHV diseases and
improved the survival capacity of those who received the
therapy. Whether HAART has altered the rate of HHV
reemergence from latency or the ability of HHVs to pro-
duce clinical manifestations is not established [8]. Clearly,
HHV-related malignancies remain a significant problem
for the HIV infected patients [9,10]. Cytomegalovirus
(CMV), Herpes Simplex virus 1 & 2 (HSV-1 & 2), Veri-
cella Zoster virus (VZV), Epstein Barr virus (EBV are the
common herpesviruses in Indian subcontinent responsi-
ble for viral OIs in HIV positive populations [11]. These
herpes viruses are usually acquired in childhood or young
adulthood, establish a state of asymptomatic latency, and
may eventually reactivate to give clinical disease later in
life or following an HIV induced decline in cell-mediated
immune control. Herpes simplex virus type 1 (HSV1) and
type 2 (HSV2) cause primary and recurrent oral, genital
and rectal ulceration and occasionally disseminated vis-
ceral and CNS disease [12]. In HIV infected individuals,
re-activation of VZV causes prolonged and severe mani-
festation of herpes zoster [7]. Retinitis is most frequent
clinical manifestation of CMV though other manifesta-
tions like gastrointestinal disease, encephalitis and pneu-
monia may occur.
In India, especially in the eastern part (including West
Bengal), limited information is available on opportunistic
infections among HIV seropositive individuals. The rela-
tive frequencies of specific opportunistic diseases may
vary in different countries and even in different areas
within the same country [[13-15], and [16]]. Early diagno-
sis of opportunistic infections and prompt treatment def-
initely contribute to increased life expectancy among
infected patients delaying the progression to AIDS [17].
In India, quite often the diagnosis of OI is made only on
clinical signs and symptoms or when illness is quite
advanced, and by then it may be polymicrobial in nature
[18,19]. Determining the spectrum of OIs and the chang-
ing pattern over the years, in a given region requires ade-
quate surveillance and good diagnostic services that are
not available in many parts of the country [20]. There is
paucity of reports about nature of etiological agents caus-
ing various clinical manifestations in HIV disease in India
[21,22]. Hence, integrated investigative procedures are
vital, especially in early stages of HIV infection. The clini-
cal manifestations of HIV infection in India (like other
developing countries) are diverse. Spectrum of OIs with
which most of the patients present in the clinics, reflects
a wide variety of other endemic diseases prevalent within
each region.
Thus, the importance of viruses in engendering many
of the secondary opportunistic illnesses (and several of
the tumors) of AIDS warrants a survey of their disease
manifestations and clinical management. Our objective
in this study therefore was to determine the prevalence of
antibodies to opportunistic viral antigens in HIV infected
Indian population. We focused primarily on the four
most prevalent viruses of the herpesviridae family found
in Eastern Indian population [22]. This study is aimed at
providing baseline data on the prevalence of various viral
OIs as part of the preliminary investigation on the
dynamics of viral opportunistic infections in immuno-
compromised population of India. The purposes of this
study were to determine the frequency of the major viral
opportunistic infections in HIV seropositive patients/
AIDS patients from Eastern India and to determine the
risk factors associated with OI at the time of diagnosis
among these patients in order to promote a greater
awareness and management of this modern day "plague"
and its complications.
Materials and methods
Study site and patient recruitment
In our study, we reviewed 200 HIV/AIDS patients, admit-
ted between January 2006 to November 2008 at Calcutta
Medical College Hospital, Kolkata, West Bengal, Apex
Clinic, Calcutta Medical College Hospital- a referral cen-
ter for patients of HIV infection or AIDS, and ART Cen-
ter, School of Tropical Medicine, for the detection of viral
opportunistic infections. Their HIV status was confirmed
by three ERS(Enzyme Linked Immunosorbent Assay
[ELISA], Rapid, Simple), an ELISA(HIV ELISA, Rapid
test)and Western Blot as recommended by the National
Aids Control Organization (NACO), Ministry of Health
and Family Welfare, Government of India. The admitted
patients were referred to us because they presented
symptoms related to HIV infection or symptoms of
unknown origin such as prolonged fever. The study group
comprised of 140 (70%) males and 60 (30%) females, with
mean ages of 36 ± 16 and 35 ± 12 years respectively. The
patients included in the study were from different states
of Eastern India. Our observations included only periods
of hospitalization; we did not investigate patients' records
after their discharge from the hospital. There were 26
males and 5 females in the patient group.
Investigation of risk factors
Written consent was obtained from all the patients and
their complete and relevant demographic information
including age, sex, ethnicity, residential history, education
status, sexual behavior, drug abuse, and other risk factors
was recorded. A medical history was obtained for each
patient, and all patients received a full clinical examina-
tion. The diagnosis of the viral opportunistic infections
was based exclusively on well defined clinical symptoms
and the determination of specific antibodies in serum byChakraborty et al. Virology Journal 2010, 7:147
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ELISA. Data representing the patient groups in various
risk factors as described in Table 1.
This study has been approved by appropriate human
subject's research review board, by the Institutional Ethi-
cal Committee of ICMR Virus Unit, Kolkata, India.
Laboratory examination and diagnosis of viral OIs
The viral OIs were primarily diagnosed by the common
clinical manifestations. For the diagnosis of CMV, the pri-
mary clinical symptoms were pneumonia, retinitis (an
infection of the eyes), blindness and gastrointestinal dis-
ease The common clinical features of CMV disease is
retinitis (which usually presents as painless, gradual loss
of vision, floaters) followed by oesophagitis (presents as
dysphagia - difficulty in swallowing or Odynophagia -
painful swallowing), colitis (presents as pain abdomen,
bloody diarrhea, fever), pneumonitis (cough, breathless-
ness), encephalitis (altered mental status, convulsion,
headache), radiculoneuropathy (weakness/paralysis of
lower limbs, pain lower back, urinary retention) etc. Pri-
mary symptoms of HSV included persistent vesicular and
ulcerative lesions of the oral and anogenital areas, often
with extensive or deep ulcerations and blisters on or
around the genitals or rectum. The blisters left tender
ulcers (sores) that took two to four weeks to heal the first
time they occurred. Other symptoms included tender
tonsils covered with a whitish substance that made swal-
lowing difficult or blisters present in the mouth. Primary
diagnosis of EBV was based on the clinical symptoms of
fever, sore throat and swollen lymph glands. The com-
monest clinical presentation of EBV disease in HIV posi-
tives is Oral hairy Leukoplakia (OHL). VZV was
primarily diagnosed based on the clinical manifestations
of severe headaches, backache, general malaise and fever
accompanied by the typical exanthem (rash) of chicken-
pox. Other symptoms of VZV included painful oral
lesions, vesicular rash, facial numbness and loss of hear-
ing/ear pain. All the clinical manifestations were con-
firmed by ELISA test done in triplicates. The following
diagnostic test kits were used for the assay of the oppor-
tunistic viruses:
Anti- CMV
Serum anti-CMV was determined by a commercially
available test kit, CMV IgM, IgG ELISA Test kit supplied
by EQUIPAR was used to detect antibodies against the
CMV-IE1 and CMV-pp65mII.
Anti - EBV 1
Serum anti-EBV was determined by a commercially avail-
able test kit, EBV IgG, IgM ELISA Test kit supplied by
Virotech/Germany was used to detect antibodies against
the affinity-purified gp125 + p18 Peptide.
Anti- HSV 2
Serum anti- HSVwas determined by a commercially
available test kit, HSV type1 IgM ELISA Test kit supplied
by EQUIPAR was used to detect antibodies against the
affinity-chromatographically purified recombinant anti-
gen HSV-2.
Anti - VZV
Serum anti-VZV was determined by a commercially
available test kit, VZV IgM, IgG, IgA ELISA Test kit sup-
plied by Virotech/Germany was used to detect antibodies
against the Ellen Strain antigen (ATCC).
Evaluation of whole blood CD4+ Lymphocyte count
The CD4+ count of the HIV seropositive patients (n =
200) was done at the discretion of the treating physicians.
The CD4+ T cell percentages and the CD4+ counts were
estimated by FACS Calibur flow cytometer (Becton Dick-
inson, San Jose, Calif., USA). Dual color immunopheno-
typing was performed using standard whole blood
methodology.
Statistical analysis
The data was analyzed by the use of MINITAB Statistical
software version 13.1. A regression model was fitted by
using the data to analyze the effect of co-variates (i.e. age,
sex, mode of infection, CD4+) on different response vari-
able (i.e. different opportunistic infection). The Chi
Square test of independence was used for statistical anal-
ysis and the Null hypothesis (H0 hypothesis) has also been
tested. A P- value of > 0.05 was regarded as statistically
significant. The mean, median, mode and standard devia-
tion has also been done by using the same software. 95%
Class Intervals and Kramer's V value, a measure of the
Table 1: The HIV-seropositive patient groups in various risk 
factors
Risk Behavior Male Female
Blood transfusion 13 6
IVD abuse 25 3
Heterosexual 82 39
Homophiles 20 12
Occupation
Unemployed 12 46
Government Service 13 -
Non Government Service 115 14
Deaths 32Chakraborty et al. Virology Journal 2010, 7:147
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strength of association among the levels of the row and
column variables were calculated according to conven-
tional methods. The purpose of the regression model and
Chi Square test is to test the effect of different covariates
on different response variables. Using the P-value
method, one can conclude whether a given covariate has
an effect on the response variable. From our data analysis,
it is clear that age, sex, mode of transmission and CD4+
count (co-variates) have effects on the OIs (response vari-
ables) of our study subjects.
Results
Of the 200 HIV/AIDS patients studied, the samples posi-
tive for CMV, HSV, VZV, and EBV are 98 (49%), 94 (47%)
52 (26%), and 65 (32.5%) respectively. The incidence of
CMV was higher among males than females 59/39. HSV
was also found to be more predominant in the males 63/
31. The incidence of VZV and EBV was also found to be
dominant in the male population, the dominancy being
46/19 and 31/21 respectively.
Age related prevalence of opportunistic viral antibodies
in the serum of 200 HIV infected patient cohorts was
assessed and results showed that individuals in the age
group of 21- 40 years had the highest incidence of viral
opportunistic infections as evident from Table. 2. The
Figure 1 shows the respective opportunistic viral serum
antibody incidence in the three age groups. The antibody
OD with mean 0.275, CI (-0.34715, 0.897152); mean
0.237, CI (-0.373, 0.846336); mean 0.183, CI (-0.2251,
0.591771) mean 0.103, CI (-0.2192, 0.328658) for CMV,
HSV, VZV and EBV respectively.
Assessment of the risk factors associated with HIV
transmission showed opportunistic viral incidence of
HSV, CMV, VZV and EBV in Table. 3. HSV infection is
found to be dominating in the heterosexual individuals
among the study group. There are no significant varia-
tions among the homophiles, the drug users and the
blood transfusion patients.
The incidence of the different viral OIs was also
assessed with respect to the CD4+ cell count/μl of blood
and patients with mean CD4+ cell count of 51-100
showed the highest prevalence of opportunistic viral anti-
bodies. This was followed by the group with CD4+ count
of 101-150, 51-100, 151-200 and >200 (data not shown).
Discussion
Since the start of the epidemic, issues related to HIV/
AIDS have had a high profile in industrialized countries.
However, the burden of the disease continues to fall most
heavily, and often less visibly in developing countries [23].
Viral opportunistic infections and HIV/AIDS having
become so intertwined have constituted a major public
health problem in the country. The opportunistic infec-
tions, therefore, play a major role in clinical presentations
and remain one of the most frequent causes of death in
these patients. However in spite of this, very little infor-
mation on viral opportunistic infections and HIV co-
infection in India is available. A few reports documented
were only on HBV-HIV co-infection [24,25]. Viral oppor-
tunistic infections have not been given their desired
attention in the Indian health care delivery system, largely
due to the dearth of information on the co-infection of
HIV positive population with viral OIs. Our study was
therefore, designed to assess the incidence of HSV, EBV,
CMV, and VZV infections among HIV patients in Eastern
India so as to provide a baseline data on the dynamics of
viral opportunistic infections in the immunocompro-
mised population of Eastern India.
Table 2: The different opportunistic viruses which infects 
HIV/AIDS patients of different age groups
Age Groups (in years)
Opportunistic 
Viruses
Sex ≤ 20 21-40 41-60
CMV Male 9 37 13
Female 5 26 8
EBV Male - 22 9
Female 2 15 4
HSV Male 9 43 11
Female 4 19 8
VZV Male 9 24 13
Female 2 10 7
Figure 1 Opportunistic viruses and CD4+ count in our patient co-
horts. The range of CD4+ counts/μL of blood are shown in index. The 
number of samples positive against the respective Opportunistic virus-
es are shown in bars corresponding to the CD4+ counts in the blood.
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Infection by cytomegalovirus (CMV) is the major cause
of morbidity and mortality in individuals with depressed
cell mediated immunity of congenital origin, iatrogenic
origin and that associated with acquired immunodefi-
ciency syndrome (AIDS). The clinical diagnosis of AIDS
with CMV infection can be difficult in the absence of
CMV retinitis, polyradiculopathy and the classical CMV
syndrome [26,27]. The diagnosis poses difficulties
because a 2-3 week period is mandatory for virus isola-
tion. While IgM antibodies as detected by ELISA corre-
late poorly with the clinical status of CMV infection and
facilities for culture are usually not available in most cen-
ters [28]. There are a few reports available of CMV infec-
tion in Indian patients with HIV/AIDS, which are based
primarily on clinical or autopsy evaluation [25,29,30]. We
found CMV as the most incidental co infection in HIV/
AIDS patient with the overall incidence of 49%.
Human immunodeficiency virus (HIV) infection is
associated with an increased risk for human herpesvi-
ruses (HHVs) and their related diseases. The incidence of
HSV in human immunodeficiency virus (HIV)-seroposi-
tive patients has not been focused, with reports generally
focusing on individual infection [31]. In this report, the
serum prevalence of HSV is found to be higher in HIV-
seropositive patients; the overall incidence is around 47%.
VZV infection, the overall incidence being 32.5% is the
third most incidental coinfection in HIV seropositive
patients. VZV is one of the common aetiological agents
of viral retinitis. Neurological complications of the reacti-
vation of VZV occur most frequently in elderly persons
and immunocompromised patients [32]. Gray et al.
reported VZV infection of the CNS in more than 4% of
p a t i e n t s  w i t h  A I D S  e x a m i n e d  a t  a u t o p s y .  I n  A I D S
patients, VZV tends to reactivate from multiple dorsal
root ganglia levels, and the disease is often disseminated.
EBV is the least prevalent among the four HHVs stud-
ied in our work which is 26% of the total. EBV has been
identified as a co-factor in the pathogenesis of a signifi-
cant proportion of HIV related lymphoproliferative dis-
orders and in oral hairy leukoplakia [33]. However, only
limited information exists on the status of EBV in the
course of HIV infection and the extent of its interaction
with HIV. There is also growing interest in the biological
properties and pathogenic potential of the different EBV
subtypes, EBV-1 and EBV-2. Serological findings and
studies in saliva and blood have indicated a high inci-
dence of EBV-2 infection in the course of HIV disease,
but there is limited information regarding its significance
[34-37].
The analysis of the association of immunological status
and the presence of viral OIs revealed that the CD4 count
was significantly associated with the presence of viral
OIs. An increasing CD4 count significantly protected
patients from expressing HHVs in our patient cohorts as
indicated by the correlation as in Figure 2. It has been
detected clinically that more frequently virus infections
are associated with the compromised immunity in HIV-
infected patients [38-41]. We found that, HIV-infected
patients with CD4+ cell counts of around 200 cells/mm3
are less likely to be infected with any virus examined here
suggesting that a higherCD4+ cell count does play a role
in immunity against virus infection. This clinical out-
come is consistent with our finding of significantly lower
CD4 cell count in HIV patients with viral OIs, indicating
that the diagnosis of viral opportunistic infections can
indeed be correlated with the clinical manifestation and
thus is helpful in predicting disease progression. Figure 3
clearly shows that the patient group with CD4+ counts
between 51 and 100 cells/μl is most susceptible to viral OI
in HIV/AIDS patient. The groups with CD4+ count less
Table 3: Association of HIV transmission Risk factors with the various Opportunistic Viruses of the patients blood samples
Risk Factors of HIV transmission
Heterosexual Homophile IDU Blood transfusion
Opportunistic Viruses Male Female Male Female Male Female Male Female
C M V 2 71 91 38 1 32 9 3
E B V 2 3 1 3 527- 2-
H S V 4 3 1 2 1 1 69373
V Z V 1 99 1 35 1 1- 6 2Chakraborty et al. Virology Journal 2010, 7:147
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than 50 cells/μl are showing least opportunistic viruses
which could be due to the advanced HAART treatment.
This study is aimed at providing baseline data on viral
opportunistic infections in HIV seropositive population
as part of the preliminary investigation on the dynamics
of viral opportunistic infections in immunocompromised
population of India. One of the major problems is the
lack of specific investigations that can provide rapid and
reliable confirmation of a clinical diagnosis. A high level
of alertness is needed at both clinical and laboratory level
and routine surveillance studies need to be undertaken.
Institutions in India and other developing countries need
to be equipped to face the emerging challenge, in the
form of updating the present knowledge, by way of edu-
cation and training of the personnel, acquisition of skills
of improved procedures, and their implementation in
appropriate settings with adequate administrative sup-
port. Further investigations have to be undertaken with
matched control samples as case control analysis with
respect to all HHV infection in HIV seropositive individ-
uals in Indian perspective.
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